Taverna Simona, Pucci Marzia, Alessandro Riccardo
Biopathology and Biomedical Methodology, Biology and Genetic Section, University of Palermo, Palermo, Italy.
Ann Transl Med. 2017 Feb;5(4):83. doi: 10.21037/atm.2017.01.53.
Extracellular vesicles (EVs) are nano-sized membrane vesicles involved in intercellular communication. EVs have pleiotropic actions in physiological and pathological conditions. The ability of EVs to transports proteins, drugs and nucleic acid, to target specific cells and to increase the stability of therapeutic cargo, make EVs interesting as new devices for the treatment of human disease. In a recently published issue of European journal of pharmaceutical sciences, Silva and colleagues reviewed the ability of EVs to modulate tissue repair and regeneration, focusing on their roles and therapeutic potential as immunomodulatory messengers. In this perspective, we discussed the open questions regarding the dual role of EVs in immune system, as well as the technical limitation of the procedure for EVs isolation and administration in clinical practices. EV-based therapies require further studies to consider EVs as promising candidate for a novel cell-free therapy in the context of regeneration medicine.
细胞外囊泡(EVs)是参与细胞间通讯的纳米级膜囊泡。EVs在生理和病理条件下具有多效性作用。EVs运输蛋白质、药物和核酸、靶向特定细胞以及提高治疗性货物稳定性的能力,使其成为治疗人类疾病的新型装置。在最近一期的《欧洲药学杂志》上,席尔瓦及其同事综述了EVs调节组织修复和再生的能力,重点关注其作为免疫调节信使的作用和治疗潜力。从这个角度出发,我们讨论了关于EVs在免疫系统中的双重作用的开放性问题,以及临床实践中EVs分离和给药程序的技术局限性。基于EVs的疗法需要进一步研究,以便在再生医学背景下将EVs视为一种有前景的新型无细胞疗法候选物。